These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12020259)

  • 1. Methylprednisolone acts on peripheral blood mononuclear cells and endothelium in inhibiting migration phenomena in patients with multiple sclerosis.
    Gelati M; Corsini E; De Rossi M; Masini L; Bernardi G; Massa G; Boiardi A; Salmaggi A
    Arch Neurol; 2002 May; 59(5):774-80. PubMed ID: 12020259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced adhesion of PBMNCs to endothelium in methylprednisolone-treated MS patients: preliminary results.
    Gelati M; Corsini E; Dufour A; Ciusani E; Massa G; Frigerio S; Milanese C; Nespolo A; Salmaggi A
    Acta Neurol Scand; 1997 Nov; 96(5):283-92. PubMed ID: 9404997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study.
    Corsini E; Gelati M; Dufour A; Massa G; Nespolo A; Ciusani E; Milanese C; La Mantia L; Salmaggi A
    J Neuroimmunol; 1997 Oct; 79(1):76-83. PubMed ID: 9357450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmigration of PBMNCs from beta-IFN-1b-treated MS patients: a one-year longitudinal study.
    Gelati M; Corsini E; Dufour A; Zaffaroni M; Milanese C; La Mantia L; Massa G; Salmaggi A
    Autoimmunity; 2001; 33(4):275-83. PubMed ID: 11683402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
    Stuve O; Chabot S; Jung SS; Williams G; Yong VW
    J Neuroimmunol; 1997 Dec; 80(1-2):38-46. PubMed ID: 9413258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
    Smith DR; Balashov KE; Hafler DA; Khoury SJ; Weiner HL
    Ann Neurol; 1997 Sep; 42(3):313-8. PubMed ID: 9307252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS.
    Elovaara I; Lällä M; Spåre E; Lehtimäki T; Dastidar P
    Neurology; 1998 Dec; 51(6):1703-8. PubMed ID: 9855526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation.
    Elovaara I; Kuusisto H; Paalavuo R; Särkijärvi S; Lehtimäki T; Huhtala H; Vilpo J
    Acta Neurol Scand; 2006 Mar; 113(3):163-6. PubMed ID: 16441245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs.
    Iba O; Matsubara H; Nozawa Y; Fujiyama S; Amano K; Mori Y; Kojima H; Iwasaka T
    Circulation; 2002 Oct; 106(15):2019-25. PubMed ID: 12370229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1.
    Zoja C; Angioletti S; Donadelli R; Zanchi C; Tomasoni S; Binda E; Imberti B; te Loo M; Monnens L; Remuzzi G; Morigi M
    Kidney Int; 2002 Sep; 62(3):846-56. PubMed ID: 12164866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.
    Martínez-Cáceres EM; Barrau MA; Brieva L; Espejo C; Barberà N; Montalban X
    Clin Exp Immunol; 2002 Jan; 127(1):165-71. PubMed ID: 11882048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier.
    Weiss JM; Downie SA; Lyman WD; Berman JW
    J Immunol; 1998 Dec; 161(12):6896-903. PubMed ID: 9862722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of junctional adhesion molecule and platelet/endothelial cell adhesion molecule-1 (CD31) at human vascular endothelial junctions by cytokines tumor necrosis factor-alpha plus interferon-gamma Does not reduce leukocyte transmigration under flow.
    Shaw SK; Perkins BN; Lim YC; Liu Y; Nusrat A; Schnell FJ; Parkos CA; Luscinskas FW
    Am J Pathol; 2001 Dec; 159(6):2281-91. PubMed ID: 11733377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study of chemokine receptor expression on peripheral lymphocytes in multiple sclerosis: CXCR3 upregulation is associated with relapse.
    Mahad DJ; Lawry J; Howell SJ; Woodroofe MN
    Mult Scler; 2003 Mar; 9(2):189-98. PubMed ID: 12708814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis.
    Salmaggi A; Gelati M; Dufour A; Corsini E; Pagano S; Baccalini R; Ferrero E; Scabini S; Silei V; Ciusani E; De Rossi M
    J Interferon Cytokine Res; 2002 Jun; 22(6):631-40. PubMed ID: 12162873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.
    Crockard AD; Treacy MT; Droogan AG; Hawkins SA
    J Neurol; 1996 Jun; 243(6):475-81. PubMed ID: 8803822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer.
    Lou J; Gasche Y; Zheng L; Giroud C; Morel P; Clements J; Ythier A; Grau GE
    Lab Invest; 1999 Aug; 79(8):1015-25. PubMed ID: 10462039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.